Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Myeloid Therapeutics
Myeloid Therapeutics
Incyte Corporation
Regeneron Pharmaceuticals
Novartis
Shattuck Labs, Inc.
UNC Lineberger Comprehensive Cancer Center
MacroGenics
Amgen
UNC Lineberger Comprehensive Cancer Center
Nurix Therapeutics, Inc.
Bicara Therapeutics
Xencor, Inc.
Toray Industries, Inc
Context Therapeutics Inc.
Arsenal Biosciences, Inc.
Lyell Immunopharma, Inc.
University of Pennsylvania
Dana-Farber Cancer Institute
Theratechnologies
University of Washington
Exelixis
Bio-Path Holdings, Inc.
Medigene AG
Carisma Therapeutics Inc
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Light Chain Bioscience - Novimmune SA
Imunon
Nerviano Medical Sciences
Hospices Civils de Lyon
Seoul National University Hospital
Hoffmann-La Roche
University Hospital, Geneva
University Medical Center Groningen
Eli Lilly and Company
Leiden University Medical Center
Instil Bio
BioEclipse Therapeutics
Mayo Clinic
Multitude Therapeutics Inc.
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center
Canadian Cancer Trials Group
Xencor, Inc.
Ludwig Institute for Cancer Research
Shanghai East Hospital
Roswell Park Cancer Institute
Southern Illinois University